UBS Downgrades Braskem to Sell, Lowers Price Target to $1.5

UBS analyst Tasso Vasconcellos has downgraded Braskem (NYSE: BAK) from Neutral to Sell, reducing the price target from $4 to $1.5. This change reflects a negative outlook on the company's performance.